These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4399567)

  • 21. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcoholic hepatitis with cirrhosis.
    Corbin P
    Nurs Mirror Midwives J; 1969 Aug; 129(9):36-8 contd. PubMed ID: 5195148
    [No Abstract]   [Full Text] [Related]  

  • 23. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study.
    Sörös P; Böttcher J; Weissenborn K; Selberg O; Müller MJ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):606-10. PubMed ID: 18005013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications of cirrhosis.
    Dong MH; Saab S
    Dis Mon; 2008 Jul; 54(7):445-56. PubMed ID: 18570914
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal failure in terminal cirrhosis of the liver.
    Thomsen AC; Juhl E
    Scand J Gastroenterol Suppl; 1970; 7():117-21. PubMed ID: 5271831
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatic encephalopathy after TIPS--retrospective study].
    Stefánková J; Fejfar T; Safka V; Hůlek P; Krajina A; Fendrichová M
    Vnitr Lek; 2002 May; 48(5):390-5. PubMed ID: 12061205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Liver damage in erythropoietic protoporphyria].
    Iwanov E; Taschev T; Krastev L; Braikov N
    Dermatol Monatsschr; 1972 Nov; 158(11):806-16. PubMed ID: 4666135
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fatal acute hepatic failure with hepatocarcinoma presentation in a patient with renal transplant with asymptomatic chronic B and C hepatitis].
    Ridruejo E; Avagnina A; Davalos Michel M; Mandó OG
    Medicina (B Aires); 2001; 61(5 Pt 1):585-8. PubMed ID: 11721327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cholestatic cirrhosis caused by lithiasic retention jaundice. Course of biliary and hepatic functions after operation].
    Langeron P; Sigam M; Puppinck P
    Lille Med; 1971 Mar; 16(3):437-41. PubMed ID: 5566806
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
    Shaposhnikova NA
    Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medical treatment of cirrhosis: general review].
    Sherlock S
    Union Med Can; 1974 Dec; 103(12):2054-7. PubMed ID: 4619235
    [No Abstract]   [Full Text] [Related]  

  • 32. Study of the prognosis of cirrhosis by means of factor analysis of correspondence and descriptive analysis.
    Gauthier A; Zurli J; Cros RC; Sarles H
    Rev Eur Etud Clin Biol; 1972; 17(6):574-81. PubMed ID: 4539651
    [No Abstract]   [Full Text] [Related]  

  • 33. Jaundice in a patient receiving acetohexamide.
    Goldstein MJ; Rothenberg AJ
    N Engl J Med; 1966 Jul; 275(2):97-9. PubMed ID: 5936873
    [No Abstract]   [Full Text] [Related]  

  • 34. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
    Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of ascites in cirrhosis of the liver].
    Del Solar V; Lobo G; Varela N; Lehmann C
    Rev Med Chil; 1965 Sep; 93(9):549-56. PubMed ID: 5888085
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coexistence of various diseases and the analysis of the causes of death in patients with liver cirrhosis].
    Marlicz K; Szymański Z; Wierzbicka-Paczos E; Tarnowska M; Kordowska M; Kotańska K
    Przegl Lek; 1984; 41(10):617-20. PubMed ID: 6336252
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nursing of patients with liver cirrhosis. Management of hepatic encephalopathy].
    Saoshiro T
    Kango Gijutsu; 1982 Dec; 28(16):2112-8. PubMed ID: 6926047
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimization of therapy in patients with hepatic cirrhosis and encephalopathy].
    Ivanov AG; Trusov VV
    Klin Med (Mosk); 2008; 86(6):62-6. PubMed ID: 18720715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.